NCT03034187 Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate
| NCT ID | NCT03034187 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Center Groningen |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 1999-04 |
| Primary Completion | 2025-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 1999-04 with a primary completion date of 2025-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal is to gain insight in the development and course of the toxicity after a curative treatment of prostate cancer
Eligibility Criteria
Inclusion Criteria: * All curative treated patients with prostatecancer( with positive lymph nodes) * All patients who will be treated with RT( including post-operative, adjuvant treatments) * Are willing to fill in toxicity and QOL-questionnarys (QLQ-PR25 en de QLQ-C30) Exclusion Criteria: Patients who are not willing to fill in toxicity and QOL-questionnarys Patients who will not get RT Non-curative or palliative treated patients (with bone mestasis) Non-prostate cancer-patients
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03034187 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03034187 currently recruiting?
Yes, NCT03034187 is actively recruiting participants. Contact the research team at s.al-uwini@umcg.nl for enrollment information.
Where is the NCT03034187 trial being conducted?
This trial is being conducted at Groningen, Netherlands.
Who is sponsoring the NCT03034187 clinical trial?
NCT03034187 is sponsored by University Medical Center Groningen. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.